Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma
Recruiting · NCT06609941 · Interventional (participants receive a specific treatment) · Lead sponsor: Foundation University Islamabad
View the official record on ClinicalTrials.gov →Interventions studied
Alternative nostril breathingPharmacological therapy
What this trial is about
Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.
Who can take part
Age range
18 Years to 45 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adults: aged (18-45 years)
- Gender: Both males and females
- Grade1- Grade 4 on Modified MRC dyspnea scale
- Asthma severity classes (intermediate, mild persistent and moderate persistent asthma) acc. to NAEPP national asthma education and prevention program guidlin
Exclusion criteria
- Patients having acute exacerbation of COPD or status asthmaticus
- Patients diagnosed with acute infections
- Patients unable to follow command/ instructions
- Asthma patients with \>40 sec control pause duration
- Patients who fall in red zone of asthma action plan (PEFR \< 50%)
Where it is running
1 location listed.
- Foundation University College of Physical Therapy - Rawalpindi, Punjab Province, Pakistan